Absorption |
Blood-Brain Barrier | BBB+ | 0.9663 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7999 |
P-glycoprotein Substrate | Substrate | 0.8077 |
P-glycoprotein Inhibitor | Inhibitor | 0.7541 |
Inhibitor | 0.6486 |
Renal Organic Cation Transporter | Inhibitor | 0.7670 |
Distribution |
Subcellular localization | Lysosome | 0.7778 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7444 |
CYP450 2D6 Substrate | Substrate | 0.7538 |
CYP450 3A4 Substrate | Substrate | 0.5410 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8788 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9136 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8154 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8904 |
CYP450 3A4 Inhibitor | Inhibitor | 0.9028 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7552 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8721 |
Inhibitor | 0.8686 |
AMES Toxicity | Non AMES toxic | 0.7805 |
Carcinogens | Non-carcinogens | 0.9031 |
Fish Toxicity | High FHMT | 0.9489 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9726 |
Honey Bee Toxicity | Low HBT | 0.8501 |
Biodegradation | Not ready biodegradable | 0.9918 |
Acute Oral Toxicity | II | 0.4643 |
Carcinogenicity (Three-class) | Non-required | 0.7130 |